1. WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects
   Fang Guan et al, 2017, Oncotarget CrossRef
2. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
   Laura De Lellis et al, 2021, Cancers CrossRef
3. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
   Eduarda Ribeiro et al, 2023, Biomedicines CrossRef
4. Induction of Programmed Cell Death in Acanthamoeba culbertsoni by the Repurposed Compound Nitroxoline
   Rubén L. Rodríguez-Expósito et al, 2023, Antioxidants CrossRef
5. Clinical trials on combination of repurposed drugs and anticancer therapies
   Süreyya Ölgen, 2020, Drug Repurposing in Cancer Therapy CrossRef
6. Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation
   Maite Ibáñez de Garayo et al, 2021, The Journal of Antibiotics CrossRef
7. In Search of a Breakthrough Therapy for Glioblastoma Multiforme
   Alex Vasilev et al, 2018, Neuroglia CrossRef
8. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
   Christina Pfab et al, 2021, Cancers CrossRef
9. Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small‐cell lung cancer
   Jin‐Guo Yu et al, 2019, The Kaohsiung Journal of Medical Sciences CrossRef
10. Copper and Antibiotics
    Alex G. Dalecki et al, 2017, Microbiology of Metal Ions CrossRef
11. Overcoming cancer therapeutic bottleneck by drug repurposing
    Zhe Zhang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
12. Drug repurposing for cancer
    Juni Banerjee et al, 2024, Clinical Application of Repurposed Drugs CrossRef
13. A Novel Electrochemical Sensing of 8-Hydroxy-5-Nitro-Quinoline Moiety using Graphene-Oxide Fabricated Glassy Carbon Electrode
    Varsha Jakhar et al, 2019, Analytical Chemistry Letters CrossRef
14. Nitroxoline Drug Combinations Are More Active Than Lyme Antibiotic Combination and Can Eradicate Stationary-Phase Borrelia burgdorferi
    Hector S. Alvarez-Manzo et al, 2022, Infectious Microbes and Diseases CrossRef
15. Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines
    Dorota Olender et al, 2018, Pharmaceuticals CrossRef
16. Drug Repositioning for Effective Prostate Cancer Treatment
    Beste Turanli et al, 2018, Frontiers in Physiology CrossRef
17. Discovery of anticancer therapeutics: Computational chemistry and Artificial Intelligence-assisted approach
    Subrata Das et al, 2023, Computational Methods in Drug Discovery and Repurposing for Cancer Therapy CrossRef
18. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma
    Jaleh Varshosaz et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
19. Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo
    Ana Mitrović et al, 2017, Oncotarget CrossRef
20. Chitosan Oligosaccharides Induce Apoptosis in Human Renal Carcinoma via Reactive-Oxygen-Species-Dependent Endoplasmic Reticulum Stress
    Xingchen Zhai et al, 2019, Journal of Agricultural and Food Chemistry CrossRef
21. Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study
    Leila Sayed-Tabatabaei et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
22. Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors
    Timo Heinrich et al, 2019, Journal of Medicinal Chemistry CrossRef
23. A quality‐by‐design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities
    Santhi Priya Lankalapalli et al, 2024, Journal of Separation Science CrossRef
24. New drugs are not enough‑drug repositioning in oncology: An update
    Romina Armando et al, 2020, International Journal of Oncology CrossRef
25. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
    Faheem Ahmed et al, 2023, Journal of Medical Virology CrossRef